METHOTREXATE SODIUM
Substance profile for UNII 3IG1E710ZN, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.
Structure render from PubChem CID 11329481Substance Identity#
- UNII
- 3IG1E710ZN
- Preferred term
- METHOTREXATE SODIUM
- Registry number
- 7413-34-5
- EC number
- 231-022-0
- Ingredient type
- INGREDIENT SUBSTANCE
- Molecular formula
- C20H20N8O5.2Na
Chemical And Database Identifiers#
- InChIKey
- DASQOOZCTWOQPA-GXKRWWSZSA-L
- SMILES
- [Na+].[Na+].CN(CC1=NC2=C(N=C1)N=C(N)N=C2N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC([O-])=O)C([O-])=O
- RxCUI
- 287734
- PubChem
- 11329481
- NCIt
- C1735
- INN ID
- 0
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| METHOTREXATE SODIUM | ACTIVE INGREDIENT | 3IG1E710ZN | METHOTREXATE (METHOTREXATE SODIUM) INJECTION, SOLUTION [HOSPIRA WORLDWIDE, INC.] | 11 | |
| METHOTREXATE SODIUM | ACTIVE INGREDIENT | 3IG1E710ZN | METHOTREXATE SODIUM TABLET [ROXANE LABORATORIES, INC] | 8 | |
| Methotrexate Sodium | ACTIVE INGREDIENT | 3IG1E710ZN | METHOTREXATE SODIUM INJECTION, SOLUTION [SANDOZ INC] | 5 | |
| METHOTREXATE SODIUM | ACTIVE INGREDIENT | 3IG1E710ZN | METHOTREXATE SODIUM TABLET [PHYSICIANS TOTAL CARE, INC.] | 4 | |
| METHOTREXATE SODIUM | ACTIVE INGREDIENT | 3IG1E710ZN | METHOTREXATE TABLET [BARR LABORATORIES INC.] | 4 | |
| METHOTREXATE SODIUM | ACTIVE INGREDIENT | 3IG1E710ZN | METHOTREXATE TABLET [PD-RX PHARMACEUTICALS, INC.] | 4 | |
| METHOTREXATE SODIUM | ACTIVE INGREDIENT | 3IG1E710ZN | METHOTREXATE (METHOTREXATE SODIUM) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 3 | |
| METHOTREXATE SODIUM | ACTIVE INGREDIENT | 3IG1E710ZN | METHOTREXATE (METHOTREXATE SODIUM) INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.] | 3 | |
| methotrexate sodium | ACTIVE INGREDIENT | 3IG1E710ZN | RASUVO (METHOTREXATE) INJECTION, SOLUTION [MEDAC PHARMA, INC] | 3 | |
| METHOTREXATE SODIUM | ACTIVE INGREDIENT | 3IG1E710ZN | TREXALL (METHOTREXATE) TABLET, FILM COATED [TEVA WOMEN'S HEALTH, INC.] | 3 | |
| METHOTREXATE SODIUM | ACTIVE INGREDIENT | 3IG1E710ZN | METHOTREXATE (METHOTREXATE SODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC] | 2 | |
| METHOTREXATE SODIUM | ACTIVE INGREDIENT | 3IG1E710ZN | METHOTREXATE (METHOTREXATE SODIUM) INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.] | 2 | |
| methotrexate sodium | ACTIVE INGREDIENT | 3IG1E710ZN | METHOTREXATE (METHOTREXATE SODIUM) TABLET [REBEL DISTRIBUTORS CORP] | 2 | |
| METHOTREXATE SODIUM | ACTIVE INGREDIENT | 3IG1E710ZN | METHOTREXATE INJECTION [MYLAN INSTITUTIONAL LLC ] | 2 | |
| METHOTREXATE SODIUM | ACTIVE INGREDIENT | 3IG1E710ZN | METHOTREXATE SODIUM TABLET [BRYANT RANCH PREPACK] | 2 | |
| METHOTREXATE SODIUM | ACTIVE INGREDIENT | 3IG1E710ZN | METHOTREXATE TABLET [DAVA PHARMACEUTICALS, INC.] | 2 | |
| METHOTREXATE SODIUM | ACTIVE INGREDIENT | 3IG1E710ZN | METHOTREXATE TABLET [DISPENSING SOLUTIONS, INC.] | 2 | |
| METHOTREXATE SODIUM | ACTIVE INGREDIENT | 3IG1E710ZN | METHOTREXATE TABLET [MAJOR PHARMACEUTICALS] | 2 | |
| METHOTREXATE SODIUM | ACTIVE INGREDIENT | 3IG1E710ZN | RHEUMATREX DOSE PACK (METHOTREXATE) TABLET [DAVA PHARMACEUTICALS, INC.] | 2 | |
| METHOTREXATE SODIUM | ACTIVE INGREDIENT | 3IG1E710ZN | METHOTREXATE (METHOTREXATE SODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC] | 1 | |
| METHOTREXATE SODIUM | ACTIVE INGREDIENT | 3IG1E710ZN | METHOTREXATE (METHOTREXATE SODIUM) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 1 | |
| METHOTREXATE SODIUM | ACTIVE INGREDIENT | 3IG1E710ZN | METHOTREXATE (METHOTREXATE SODIUM) INJECTION, SOLUTION [HOSPIRA WORLDWIDE, INC.] | 1 | |
| METHOTREXATE SODIUM | ACTIVE INGREDIENT | 3IG1E710ZN | METHOTREXATE (METHOTREXATE SODIUM) INJECTION, SOLUTION [HOSPIRA WORLDWIDE, INC.] | 1 | |
| METHOTREXATE SODIUM | ACTIVE INGREDIENT | 3IG1E710ZN | METHOTREXATE (METHOTREXATE SODIUM) INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.] | 1 | |
| METHOTREXATE SODIUM | ACTIVE INGREDIENT | 3IG1E710ZN | METHOTREXATE (METHOTREXATE) TABLET [AVKARE, INC.] | 1 | |
| METHOTREXATE SODIUM | ACTIVE INGREDIENT | 3IG1E710ZN | METHOTREXATE SODIUM INJECTION, SOLUTION [MYLAN INSTITUTIONAL LLC ] | 1 | |
| METHOTREXATE SODIUM | ACTIVE INGREDIENT | 3IG1E710ZN | METHOTREXATE SODIUM INJECTION, SOLUTION [PFIZER LABORATORIES DIV PFIZER INC.] | 1 | |
| METHOTREXATE SODIUM | ACTIVE INGREDIENT | 3IG1E710ZN | METHOTREXATE SODIUM TABLET [GENPAK SOLUTIONS LLC] | 1 | |
| METHOTREXATE SODIUM | ACTIVE INGREDIENT | 3IG1E710ZN | METHOTREXATE SODIUM TABLET [REMEDYREPACK INC. ] | 1 | |
| METHOTREXATE SODIUM | ACTIVE INGREDIENT | 3IG1E710ZN | METHOTREXATE SODIUM TABLET [REMEDYREPACK INC. ] | 1 | |
| METHOTREXATE SODIUM | ACTIVE INGREDIENT | 3IG1E710ZN | METHOTREXATE TABLET [PD-RX PHARMACEUTICALS, INC.] | 1 | |
| METHOTREXATE SODIUM | ACTIVE INGREDIENT | 3IG1E710ZN | METHOTREXATE TABLET [REBEL DISTRIBUTORS CORP] | 1 | |
| METHOTREXATE SODIUM | ACTIVE INGREDIENT | 3IG1E710ZN | METHOTREXATE TABLET [REMEDYREPACK INC. ] | 1 | |
| METHOTREXATE SODIUM | ACTIVE INGREDIENT | 3IG1E710ZN | METHOTREXATE TABLET [REMEDYREPACK INC. ] | 1 | |